New York State Common Retirement Fund
STOK icon

New York State Common Retirement Fund’s Stoke Therapeutics STOK Stock Holding History

New York State Common Retirement Fund’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Buy
49,611
+10,453
+27% +$335K ﹤0.01% 1547
2026
Q1 		$1.27M Buy
39,158
+24,123
+160% +$791K ﹤0.01% 1573
2025
Q4 		$477K Hold
15,035
– – ﹤0.01% 1982
2025
Q3 		$353K Buy
15,035
+4,400
+41% +$75.4K ﹤0.01% 2069
2025
Q2 		$121K Hold
10,635
– – ﹤0.01% 2475
2025
Q1 		$70.7K Hold
10,635
– – ﹤0.01% 2658
2024
Q4 		$117K Hold
10,635
– – ﹤0.01% 2529
2024
Q3 		$131K Hold
10,635
– – ﹤0.01% 2480
2024
Q2 		$144K Buy
10,635
+52
+0.5% +$702 ﹤0.01% 2575
2024
Q1 		$143K Sell
10,583
-59
-0.6% -$357 ﹤0.01% 2595
2023
Q4 		$56K Sell
10,642
-46
-0.4% -$197 ﹤0.01% 2961
2023
Q3 		$42.1K Buy
10,688
+122
+1% +$802 ﹤0.01% 3070
2023
Q2 		$112K Sell
10,566
-3,832
-27% -$40.8K ﹤0.01% 2741
2023
Q1 		$120K Hold
14,398
– – ﹤0.01% 2764
2022
Q4 		$133K Buy
14,398
+3
+0% +$31 ﹤0.01% 2877
2022
Q3 		$185K Buy
14,395
+66
+0.5% +$1.05K ﹤0.01% 2799
2022
Q2 		$189K Sell
14,329
-46
-0.3% -$699 ﹤0.01% 2817
2022
Q1 		$303K Buy
14,375
+17
+0.1% +$340 ﹤0.01% 2646
2021
Q4 		$344K Sell
14,358
-2,243
-14% -$53.5K ﹤0.01% 2640
2021
Q3 		$422K Buy
16,601
+94
+0.6% +$2.62K ﹤0.01% 2558
2021
Q2 		$556K Buy
16,507
+3,307
+25% +$117K ﹤0.01% 2539
2021
Q1 		$513K Buy
13,200
+2,100
+19% +$120K ﹤0.01% 2444
2020
Q4 		$687K Hold
11,100
– – ﹤0.01% 2194
2020
Q3 		$372K Hold
11,100
– – ﹤0.01% 2356
2020
Q2 		$265K Buy
11,100
+1,500
+16% +$35.6K ﹤0.01% 2528
2020
Q1 		$220K Hold
9,600
– – ﹤0.01% 2419
2019
Q4 		$272K Hold
9,600
– – ﹤0.01% 2585
2019
Q3 		$206K Buy
+9,600
New +$268K ﹤0.01% 2756

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

New York State Common Retirement Fund's STOK Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Stoke Therapeutics (STOK) stake by 27% in Q2 2026, buying an estimated $335K and bringing the position to 49,611 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1547.

New York State Common Retirement Fund first reported a position in STOK in Q3 2019 and has held it in 28 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • New York State Common Retirement Fund held 49,611 shares of Stoke Therapeutics worth $1.62M as of Q2 2026.
  • New York State Common Retirement Fund bought 10,453 Stoke Therapeutics shares in Q2 2026, an estimated $335K.
  • Stoke Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1547 holding.
  • New York State Common Retirement Fund first reported a position in Stoke Therapeutics in Q3 2019 and has held it in 28 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.